George Budwell

George Budwell

TMFGBudwell

George Budwell has been writing about healthcare and biotechnology companies at the Motley Fool since 2013. His primary interests are novel small molecule drugs, next generation vaccines, and cell therapies.

Recent articles

dividend

Why Evofem Biosciences Stock Is on Fire Today

Evofem Biosciences scored a major regulatory win last Friday.


SARS2_Vaccine

Why Novavax Stock Is Skyrocketing Tuesday

Novavax's experimental COVID-19 vaccine has officially entered an early-stage trial.


COVID vaccine

Why Dynavax Technologies Is Jumping Today

Dynavax's COVID-19 vaccine program is turning heads this morning.


high growth (2)

Why Novavax Is Blasting Higher Today

The clinical biotech is benefiting from an analyst upgrade and optimism about its pipeline.


marijuana bush

Why Aurora Cannabis Stock Is Soaring Today

The marijuana specialist's better-than-expected third-quarter 2020 earnings report has investors excited.

biotech researcher

Why Sorrento Therapeutics Stock Is on Fire Today

Sorrento's shares are continuing their surge from last Friday. Here's why.


canopy view

Why Aphria's Stock Crushed It in April

Aphria's shares surged higher last month on the heels of a strong Q3 report.


Female cancer patients

Why Clovis Oncology Stock Marched Higher in April

Clovis Oncology's stock reversed course last month.


Excited kid

Why MyoKardia Stock Is on Fire Today

The company's experimental heart drug hit the mark in a pivotal study.


diabetes2

Why DexCom Stock Rocketed Higher in April

DexCom's shares have been crushing it of late.

liver

Why Intercept Pharmaceuticals Stock Caught Fire in April

A recovery from a March decline and the possibility of a megablockbuster drug sent shares up 40%.


COVID19

Why Amgen Soared in April

Amgen's stock ripped higher in April. Here's why.


Biotech concept

3 Best Healthcare Stocks to Buy in May

AbbVie, Adverum Biotechnologies, and Heron Therapeutics could all be gearing up for a strong May. Here's why.


pharma money sign

2 Best Pharma Stocks to Buy in May

AstraZeneca and Bristol Myers Squibb should both deliver outstandings returns for investors this month and beyond.


biotech2

Why Adverum Biotechnologies Stock Is Soaring Today

Adverum's lead gene therapy candidate continues to impress in its early-stage trial.

Winning

Why Agile Therapeutics Stock Is Jumping Today

Agile's shares are heating up ahead of the company's Q1 earnings report.


May

The 3 Best Stocks to Buy in May

AT&T, Berkshire Hathaway, and Gilead Sciences are all strong buys this month.


Coronavirus

Inovio Pharmaceuticals, Mesoblast, and Moderna: Are These Red-Hot Biotech Stocks Still a Buy?

The COVID-19 pandemic has been a major catalyst for these three biotech stocks.


filthy rich

2 Top Biotech Stocks Under $10

Amarin and Atara Biotherapeutics could both be diamonds in the rough.


five dollar bill

3 Top Stocks Under $5 to Buy Now

Agenus, Dynavax Technologies, and Verastem Oncology could all be outstanding picks for risk-tolerant investors.